Inflammatory Tumor Hubs are an Early Marker of Resistance to Neoadjuvant Chemo-Immunotherapy in Diffuse Pleural Mesotheliomas: The NeoMeso-1 Trial

Zenodo (CERN European Organization for Nuclear Research) 2026 Dataset Open access

Read full text
Authors: Matthew Zatzman
DOI: 10.5281/zenodo.17398567
Cited by: 0

Fields of Study & Subjects

Occupational and environmental lung diseases Intraperitoneal and Appendiceal Malignancies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
13 March 2026
Language
EN
Document type
Dataset